iShares China Large-Cap ETF vs 10X Genomics Inc — how do they compare? iShares China Large-Cap ETF trades at $35.35, while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| FXI | TXG | |
|---|---|---|
52-Week High | $41.75 | $58.57 |
52-Week Low | $31.59 | $11.34 |
Market Cap | — | $7.61B |
Sector | — | Health |
Enterprise Value | — | $7.14B |
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →